Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Francois MULLIER is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The COVILAB project : Clinical laboratory investigations related to COVID-19
Douxfils, J., Dogne, J., FAVRESSE, J., Tre-Hardy, M., MULLIER, F., Haguet, H., Hardy, M., Melchionda, S., BOUVY, C., Morimont, L., Gillot, C., Djokoto, H., Alpan, L., Devel, P., Modaffari, E. & Maloteau, V.
13/03/20 → …
Project: Research
-
The DIT project : Drug induced thrombosis - a special focus on kinase and PARP inhibitors and
Douxfils, J., MULLIER, F., Haguet, H. & RONVAUX, L.
1/09/15 → …
Project: Research
-
The BIOCOAG project : Biological assessment of the control of anticoagulation
Douxfils, J., MULLIER, F., Dogne, J., Siriez, R. & Evrard, J.
1/09/11 → …
Project: Research
-
Assessment of frailty in older patients before cardiac surgery
de SAINT HUBERT, M., GOURDIN, M., Michaux, I., TOUSSAINT, O., Caron, N. & MULLIER, F.
1/04/12 → 31/12/13
Project: Research
-
D-dimer testing: A narrative review
Wauthier, L., Favresse, J., Hardy, M., Douxfils, J., Le Gal, G., Roy, P. M., van Es, N., Ay, C., Ten Cate, H., Lecompte, T., Lippi, G. & Mullier, F., Jan 2023, In: Advances in clinical chemistry. 114, p. 151-223 73 p.Research output: Contribution to journal › Review article › peer-review
-
Minimal requirements for ISO15189 validation and accreditation of three next generation sequencing procedures for SARS-CoV-2 surveillance in clinical setting
Maschietto, C., Otto, G., Rouzé, P., Debortoli, N., Bihin, B., Nyinkeu, L., Denis, O., Huang, T. D., Mullier, F., Bogaerts, P. & Degosserie, J., Dec 2023, In: Scientific Reports. 13, 1, 6934.Research output: Contribution to journal › Article › peer-review
Open Access -
Variability among commercial batches of normal pooled plasma in lupus anticoagulant testing
Cabo, J., Morimont, L., Baudar, J., Guldenpfennig, M., Jacqmin, H., Soleimani, R., Lecompte, T., Douxfils, J. & Mullier, F., Feb 2023, In: International Journal of Laboratory Hematology. 45, 1, p. 126-136 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile35 Downloads (Pure) -
Analytical Sensitivity of Six SARS-CoV-2 Rapid Antigen Tests for Omicron versus Delta Variant
Bayart, J-L., Degosserie, J., Favresse, J., Gillot, C., Didembourg, M., Djokoto, H. P., Verbelen, V., Roussel, G., Maschietto, C., Mullier, F., Dogné, J-M. & Douxfils, J., 22 Mar 2022, In: Viruses. 14, 4, 654.Research output: Contribution to journal › Article › peer-review
Open AccessFile37 Downloads (Pure) -
Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy controls
Evrard, J., Siriez, R., Bouvy, C., Favresse, J., Yildiz, H., Hainaut, P., Mullier, F., Dogné, J-M. & Douxfils, J., Oct 2022, In: Research and Practice in Thrombosis and Haemostasis. 6, 7, p. e12804 e12804.Research output: Contribution to journal › Article › peer-review
Open AccessFile27 Downloads (Pure)
Datasets
-
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), Chatelain, C. (Contributor), MULLIER, F. (Contributor), Haguet, H. (Contributor), Dogne, J. (Contributor) & Douxfils, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
Prizes
-
Prix Léo Pharma Cancer & Thrombosis
Haguet, Helene (Recipient), Douxfils, Jonathan (Recipient), MULLIER, Francois (Recipient) & Dogne, Jean-Michel (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
-
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
21 Mar 2019Activity: Talk or presentation types › Oral presentation
-
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker), François Mullier (Speaker) & Jean-Michel Dogne (Speaker)
9 Feb 2018Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
25 Feb 2017Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
28 Apr 2016Activity: Talk or presentation types › Oral presentation
-
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), Jonathan Douxfils (Speaker), François Mullier (Speaker), Christian Chatelain (Speaker), Carlos Graux (Speaker) & Jean-Michel Dogne (Speaker)
29 Jan 2016Activity: Talk or presentation types › Oral presentation
Thesis
-
Quantification and characterization of microvesicles: applications in hereditary spherocytosis, type-II heparin-induced thrombocytopenia and cancer
Author: Mullier, F., 26 Mar 2012Supervisor: Dogne, J. (Supervisor), Masereel, B. (President), Chatelain, B. (External person) (Co-Supervisor), Michiels, C. (Jury), Latinne, D. (External person) (Jury), Chatelain, C. (External person) (Jury), Wallemacq, P. (External person) (Jury), Harrison, P. A. (External person) (Jury) & Hoylaerts, M. F. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Press/Media
-
Study Results from University of Namur Broaden Understanding of Coxsackievirus (Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome)
Jean-Michel Dogne, Jonathan Douxfils, Francois MULLIER, Julien FAVRESSE & Constant Gillot
10/01/23
1 item of Media coverage
Press/Media: Expert Comment
-
New Thrombosis Study Findings Recently Were Published by Researchers at Catholic University of Louvain (UCLouvain) (Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system)
Francois MULLIER & Bernard Chatelain
28/12/22
1 item of Media coverage
Press/Media: Expert Comment
-
Department of Laboratory Medicine Researchers Provide New Data on Pulmonary Embolism (D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review)
Julien FAVRESSE & Francois MULLIER
9/12/22
1 item of Media coverage
Press/Media: Expert Comment
-
Reports from Namur Research Institute for Life Sciences (NARILIS) Add New Data to Research in Thrombosis and Haemostasis (Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban-treated patients and healthy ...)
Romain Siriez, Jonathan Evrard, Julien FAVRESSE, Jean-Michel Dogne, Jonathan Douxfils, Francois MULLIER & Celine BOUVY
24/11/22
1 item of Media coverage
Press/Media: Expert Comment